Cargando…

Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma

SIMPLE SUMMARY: A prospective evaluation of laparoscopic microwave ablation (MWA) of hepatocellular carcinoma is underutilized and predictors of patient selection and survival in this setting are not well characterized. Preoperative single lesions, “pusher” radiographic presentation, and total bilir...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Robert C. G., Woeste, Matthew, Egger, Michael E., Scoggins, Charles R., McMasters, Kelly M., Philips, Prejesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093561/
https://www.ncbi.nlm.nih.gov/pubmed/37046625
http://dx.doi.org/10.3390/cancers15071965
_version_ 1785023616016973824
author Martin, Robert C. G.
Woeste, Matthew
Egger, Michael E.
Scoggins, Charles R.
McMasters, Kelly M.
Philips, Prejesh
author_facet Martin, Robert C. G.
Woeste, Matthew
Egger, Michael E.
Scoggins, Charles R.
McMasters, Kelly M.
Philips, Prejesh
author_sort Martin, Robert C. G.
collection PubMed
description SIMPLE SUMMARY: A prospective evaluation of laparoscopic microwave ablation (MWA) of hepatocellular carcinoma is underutilized and predictors of patient selection and survival in this setting are not well characterized. Preoperative single lesions, “pusher” radiographic presentation, and total bilirubin < 2, and AFP < 20 ng/mL independently predict PFS and OS following operative MWA. ABSTRACT: Background: Laparoscopic microwave ablation (MWA) of hepatocellular carcinoma is underutilized and predictors of survival in this setting are not well characterized. Methods: The prognostic value of clinicopathologic variables was evaluated on progression-free survival (PFS) and overall survival (OS) by univariate and multivariate analyses. The aim of this study was to evaluate a preferred laparoscopic MWA approach in HCC patients that are not candidates for percutaneous ablation and further classify clinicopathologic factors that may predict survival outcomes following operative MWA in the setting of primary HCC. Results: 184 patients with HCC (median age 66, (33–86), 70% male) underwent laparoscopic MWA (N = 162, 88% laparoscopic) compared to 12% undergoing open MWA (N = 22). Median PFS was 29.3 months (0.2–170) and OS was 44.2 months (2.8–170). Ablation success was confirmed in 100% of patients. Ablation recurrence occurred in 3% (6/184), and local/hepatic recurrence occurred in 34%, at a median time of 19 months (9–18). Distant progression was noted in 8%. Median follow up was 34.1 months (6.4–170). Procedure-related complications were recorded in six (9%) patients with one 90-day mortality. Further, >1 lesion, AFP levels ≥ 80 ng/mL, and an “invader” on pre-operative radiology were associated with increased risk of progression (>1 lesion HR 2.92, 95% CI 1.06 –7.99, p = 0.04, AFP ≥ 80 ng/mL HR 4.16, 95% CI 1.71–10.15, p = 0.002, Invader HR 3.16, 95% CI 1.91–9.15, p = 0.002 ) and mortality (>1 lesion HR 3.62, 95% CI 1.21–10.81, p = 0.02], AFP ≥ 80 ng/mL HR 2.87, 95% CI 1.12–7.35, p = 0.01, Invader HR 3.32, 95% CI 1.21–9.81, p = 0.02). Conclusions: Preoperative lesion number, AFP ≥ 80 ng/mL, and an aggressive imaging characteristic (Invader) independently predict PFS and OS following laparoscopic operative MWA.
format Online
Article
Text
id pubmed-10093561
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100935612023-04-13 Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma Martin, Robert C. G. Woeste, Matthew Egger, Michael E. Scoggins, Charles R. McMasters, Kelly M. Philips, Prejesh Cancers (Basel) Article SIMPLE SUMMARY: A prospective evaluation of laparoscopic microwave ablation (MWA) of hepatocellular carcinoma is underutilized and predictors of patient selection and survival in this setting are not well characterized. Preoperative single lesions, “pusher” radiographic presentation, and total bilirubin < 2, and AFP < 20 ng/mL independently predict PFS and OS following operative MWA. ABSTRACT: Background: Laparoscopic microwave ablation (MWA) of hepatocellular carcinoma is underutilized and predictors of survival in this setting are not well characterized. Methods: The prognostic value of clinicopathologic variables was evaluated on progression-free survival (PFS) and overall survival (OS) by univariate and multivariate analyses. The aim of this study was to evaluate a preferred laparoscopic MWA approach in HCC patients that are not candidates for percutaneous ablation and further classify clinicopathologic factors that may predict survival outcomes following operative MWA in the setting of primary HCC. Results: 184 patients with HCC (median age 66, (33–86), 70% male) underwent laparoscopic MWA (N = 162, 88% laparoscopic) compared to 12% undergoing open MWA (N = 22). Median PFS was 29.3 months (0.2–170) and OS was 44.2 months (2.8–170). Ablation success was confirmed in 100% of patients. Ablation recurrence occurred in 3% (6/184), and local/hepatic recurrence occurred in 34%, at a median time of 19 months (9–18). Distant progression was noted in 8%. Median follow up was 34.1 months (6.4–170). Procedure-related complications were recorded in six (9%) patients with one 90-day mortality. Further, >1 lesion, AFP levels ≥ 80 ng/mL, and an “invader” on pre-operative radiology were associated with increased risk of progression (>1 lesion HR 2.92, 95% CI 1.06 –7.99, p = 0.04, AFP ≥ 80 ng/mL HR 4.16, 95% CI 1.71–10.15, p = 0.002, Invader HR 3.16, 95% CI 1.91–9.15, p = 0.002 ) and mortality (>1 lesion HR 3.62, 95% CI 1.21–10.81, p = 0.02], AFP ≥ 80 ng/mL HR 2.87, 95% CI 1.12–7.35, p = 0.01, Invader HR 3.32, 95% CI 1.21–9.81, p = 0.02). Conclusions: Preoperative lesion number, AFP ≥ 80 ng/mL, and an aggressive imaging characteristic (Invader) independently predict PFS and OS following laparoscopic operative MWA. MDPI 2023-03-25 /pmc/articles/PMC10093561/ /pubmed/37046625 http://dx.doi.org/10.3390/cancers15071965 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Martin, Robert C. G.
Woeste, Matthew
Egger, Michael E.
Scoggins, Charles R.
McMasters, Kelly M.
Philips, Prejesh
Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma
title Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma
title_full Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma
title_fullStr Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma
title_full_unstemmed Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma
title_short Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma
title_sort patient selection and outcomes of laparoscopic microwave ablation of hepatocellular carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093561/
https://www.ncbi.nlm.nih.gov/pubmed/37046625
http://dx.doi.org/10.3390/cancers15071965
work_keys_str_mv AT martinrobertcg patientselectionandoutcomesoflaparoscopicmicrowaveablationofhepatocellularcarcinoma
AT woestematthew patientselectionandoutcomesoflaparoscopicmicrowaveablationofhepatocellularcarcinoma
AT eggermichaele patientselectionandoutcomesoflaparoscopicmicrowaveablationofhepatocellularcarcinoma
AT scogginscharlesr patientselectionandoutcomesoflaparoscopicmicrowaveablationofhepatocellularcarcinoma
AT mcmasterskellym patientselectionandoutcomesoflaparoscopicmicrowaveablationofhepatocellularcarcinoma
AT philipsprejesh patientselectionandoutcomesoflaparoscopicmicrowaveablationofhepatocellularcarcinoma